Literature DB >> 19319634

Recent results of therapy for scirrhous gastric cancer.

Masahide Ikeguchi1, Takanori Miyake, Tomoyuki Matsunaga, Manabu Yamamoto, Youji Fukumoto, Yosinori Yamada, Kenji Fukuda, Hiroaki Saito, Shigeru Tatebe, Shun-ichi Tsujitani.   

Abstract

The prognosis of patients with scirrhous gastric cancer (SGC) is extremely poor. However, recent advances in therapeutic strategies against SGC, using effective anticancer drugs, have prolonged the survival of patients with SGC. This paper reviews the recent therapeutic outcomes of this type of gastric cancer and introduces a new treatment protocol for SGC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19319634     DOI: 10.1007/s00595-008-3860-1

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  47 in total

1.  Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis.

Authors:  Giovanni Carlo Cesana; Fabrizio Romano; Gaia Piacentini; Marco Scotti; Ambrogio Brenna; Giorgio Bovo; Massimo Vaghi; Giacomo Aletti; Roberto Caprotti; Howard Kaufman; Franco Uggeri
Journal:  Ann Surg Oncol       Date:  2007-01-17       Impact factor: 5.344

2.  Neoadjuvant treatment of gastric cancer with peritoneal dissemination.

Authors:  Y Yonemura; E Bandou; T Sawa; Y Yoshimitsu; Y Endou; T Sasaki; P H Sugarbaker
Journal:  Eur J Surg Oncol       Date:  2006-04-18       Impact factor: 4.424

3.  A randomized phase III trial of postoperative adjuvant therapy with S-1 alone versus S-1 plus PSK for stage II/IIIA gastric cancer: Hokuriku-Kinki Immunochemo-Therapy Study Group-Gastric Cancer (HKIT-GC).

Authors:  Yuji Ueda; Takashi Fujimura; Shinichi Kinami; Yasuo Hirono; Akio Yamaguchi; Hiroyuki Naitoh; Tohru Tani; Masahide Kaji; Hisakazu Yamagishi; Koichi Miwa
Journal:  Jpn J Clin Oncol       Date:  2006-06-27       Impact factor: 3.019

4.  Adjuvant intraperitoneal chemotherapy with cisplatinum, mitoxantrone, 5-fluorouracil, and calcium folinate in patients with gastric cancer: a phase II study.

Authors:  Erkan Topuz; Mert Basaran; Pinar Saip; Adnan Aydiner; Andac Argon; Burak Sakar; Faruk Tas; Kazim Uygun; Dursun Bugra; N Faruk Aykan
Journal:  Am J Clin Oncol       Date:  2002-12       Impact factor: 2.339

5.  Extended surgery--left upper abdominal exenteration plus Appleby's method--for type 4 gastric carcinoma.

Authors:  H Furukawa; M Hiratsuka; T Iwanaga; S Imaoka; O Ishikawa; T Kabuto; Y Sasaki; M Kameyama; H Ohigashi; S Nakamori; T Yasuda
Journal:  Ann Surg Oncol       Date:  1997 Apr-May       Impact factor: 5.344

6.  Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.

Authors:  Y Hippo; M Yashiro; M Ishii; H Taniguchi; S Tsutsumi; K Hirakawa; T Kodama; H Aburatani
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

7.  Laparoscopy in the management of scirrhous gastric cancer.

Authors:  Norio Shiraishi; Akio Morimoto; Koich Sato; Toshio Bandoh; Yosuke Adachi; Seigo Kitano
Journal:  Gastric Cancer       Date:  1999-08       Impact factor: 7.370

8.  Unusual survival for more than 2 years with peritoneal metastases of gastric cancer.

Authors:  Osamu Kobayashi; Kazuo Konishi; Masahiro Kanari; Haruhiko Cho; Takaki Yoshikawa; Akira Tsuburaya; Motonori Sairenji; Hisahiko Motohashi
Journal:  Gastric Cancer       Date:  2002       Impact factor: 7.370

Review 9.  Results of radiation therapy in gastric cancer.

Authors:  Christopher G Willett
Journal:  Semin Radiat Oncol       Date:  2002-04       Impact factor: 5.934

Review 10.  Adjuvant chemotherapy for gastric cancer in Japan: global and Japanese perspectives.

Authors:  Junichi Sakamoto; Satoshi Morita; Yasuhiro Kodera; Mahbubur Rahman; Akimasa Nakao
Journal:  Cancer Chemother Pharmacol       Date:  2004-09       Impact factor: 3.333

View more
  23 in total

1.  Usefulness of staging laparoscopy for advanced gastric cancer.

Authors:  Hiroki Shimizu; Hiroshi Imamura; Katsuya Ohta; Yasuhiro Miyazaki; Tomono Kishimoto; Mutsumi Fukunaga; Hiroki Ohzato; Masayuki Tatsuta; Hiroshi Furukawa
Journal:  Surg Today       Date:  2010-01-28       Impact factor: 2.549

2.  Biological significance of localized Type IV scirrhous gastric cancer.

Authors:  Kazuya Endo; Masato Sakurai; Eiji Kusumoto; Hideo Uehara; Shohei Yamaguchi; Norifumi Tsutsumi; Koji Ikejiri
Journal:  Oncol Lett       Date:  2011-10-21       Impact factor: 2.967

3.  Cancer-stromal interactions in scirrhous gastric carcinoma.

Authors:  Masakazu Yashiro; Kosei Hirakawa
Journal:  Cancer Microenviron       Date:  2010-01-26

4.  Prognostic nutritional index: a tool to predict the biological aggressiveness of gastric carcinoma.

Authors:  Tadahiro Nozoe; Mizuki Ninomiya; Takashi Maeda; Akito Matsukuma; Hideaki Nakashima; Takahiro Ezaki
Journal:  Surg Today       Date:  2010-04-28       Impact factor: 2.549

5.  Intraperitoneal administration of cisplatin via an in situ cross-linkable hyaluronic acid-based hydrogel for peritoneal dissemination of gastric cancer.

Authors:  Shigenobu Emoto; Hironori Yamaguchi; Takao Kamei; Hironori Ishigami; Takashi Suhara; Yukimitsu Suzuki; Taichi Ito; Joji Kitayama; Toshiaki Watanabe
Journal:  Surg Today       Date:  2013-07-26       Impact factor: 2.549

6.  Primary colorectal signet-ring cell carcinoma: clinicopathological features and postoperative survival.

Authors:  Tsunekazu Mizushima; Masaya Nomura; Makoto Fujii; Hiroki Akamatsu; Hitoshi Mizuno; Harumi Tominaga; Junichi Hasegawa; Kiyokazu Nakajima; Keigo Yasumasa; Masato Yoshikawa; Toshirou Nishida
Journal:  Surg Today       Date:  2010-02-24       Impact factor: 2.549

Review 7.  Genomic and epigenetic profiles of gastric cancer: potential diagnostic and therapeutic applications.

Authors:  Keishi Yamashita; Shinichi Sakuramoto; Masahiko Watanabe
Journal:  Surg Today       Date:  2010-12-30       Impact factor: 2.549

Review 8.  Rho/ROCK signaling in motility and metastasis of gastric cancer.

Authors:  Tasuku Matsuoka; Masakazu Yashiro
Journal:  World J Gastroenterol       Date:  2014-10-14       Impact factor: 5.742

9.  Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells.

Authors:  O Shinto; M Yashiro; H Kawajiri; K Shimizu; T Shimizu; A Miwa; K Hirakawa
Journal:  Br J Cancer       Date:  2010-02-09       Impact factor: 7.640

10.  Suppressive effect of bevacizumab on peritoneal dissemination from gastric cancer in a peritoneal metastasis model.

Authors:  Takuya Imaizumi; Keishiro Aoyagi; Motoshi Miyagi; Kazuo Shirouzu
Journal:  Surg Today       Date:  2010-08-26       Impact factor: 2.549

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.